Phenotype and Clinical Outcomes of Titin Cardiomyopathy

Journal of the American College of Cardiology

Volumn 70, Issue 18, 2017, Pages 2264-2274

  Tayal, Upasana ^a,b   Newsome, Simon ^c   Buchan, Rachel ^a,b   Whiffin, Nicola ^a,b,d   Halliday, Brian ^a,b   Lota, Amrit ^a,b   Roberts, Angharad ^b   Baksi, A John ^a,b   Voges, Inga ^b   Midwinter, Will ^b   Wilk, Alijca ^b   Govind, Risha ^b   Walsh, Roddy ^a,b   Daubeney, Piers ^b   Jarman, Julian W E ^b   Baruah, Resham ^b   Frenneaux, Michael ^a,b   Barton, Paul J ^a,b   Pennell, Dudley ^b   Ware, James S ^a,b,d   Prasad, Sanjay K ^a,b   Cook, Stuart A ^a,b,d,e,f   more..

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e DEPARTMENT OF CARDIOLOGY   (Singapore)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

CMR; DCM; genetics; titin

Indexed keywords

CONNECTIN; GADOLINIUM; TTN PROTEIN, HUMAN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CLINICAL EVALUATION; CLINICAL OUTCOME; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TTNTV GENE; ADOLESCENT; AGED; CHILD; DIAGNOSTIC IMAGING; GENETICS; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; CHILD; COHORT STUDIES; CONNECTIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85032841120     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.08.063     Document Type: Article

References (25)

1. Hershberger, R.E., Hedges, D.J., Morales, A., Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10 (2013), 531–547.
2. Maron, B.J., Towbin, J.A., Thiene, G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006), 1807–1816.
3. International Society of Heart and Lung Transplantation Quarterly Report. 2015 edition. Available at: https://www.ishlt.org/registries/quarterlyDataReportStep3.asp?organ=HR&rptType=tx_char. Accessed September 9, 2017.
4. Kober, L., Thune, J.J., Nielsen, J.C., et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375 (2016), 1221–1230.
5. Gulati, A., Jabbour, A., Ismail, T.F., et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309 (2013), 896–908.
6. Roberts, A.M., Ware, J.S., Herman, D.S., et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med, 7, 2015, 270ra276.
7. Herman, D.S., Lam, L., Taylor, M.R., et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366 (2012), 619–628.
8. Franaszczyk, M., Chmielewski, P., Truszkowska, G., et al. Titin truncating variants in dilated cardiomyopathy–prevalence and genotype-phenotype correlations. PLoS One, 12, 2017, e0169007.
9. Jansweijer, J.A., Nieuwhof, K., Russo, F., et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail 19 (2017), 512–521.
10. Maceira, A.M., Prasad, S.K., Khan, M., Pennell, D.J., Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8 (2006), 417–426.
11. Burkett, E.L., Hershberger, R.E., Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45 (2005), 969–981.
12. van Rijsingen, I.A., Arbustini, E., Elliott, P.M., et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 59 (2012), 493–500.
13. Tayal, U., Newsome, S., Buchan, R., et al. Truncating variants in titin independently predict early arrhythmias in patients with dilated cardiomyopathy. J Am Coll Cardiol 69 (2017), 2466–2468.
14. Gulati, A., Ismail, T.F., Jabbour, A., et al. Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 15 (2013), 660–670.
15. Pua, C.J., Bhalshankar, J., Miao, K., et al. Development of a comprehensive sequencing assay for inherited cardiac condition genes. J Cardiovasc Transl Res 9 (2016), 3–11.
16. Hicks, K.A., Tcheng, J.E., Bozkurt, B., et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66 (2015), 403–469.
17. Zipes, D.P., Camm, A.J., Borggrefe, M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006), e247–e346.
18. Aleksova, A., Sabbadini, G., Merlo, M., et al. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure—a subgroup analysis from the Trieste Cardiomyopathy Registry. J Cardiovasc Med (Hagerstown) 10 (2009), 699–705.
19. Halliday, B., Gulati, A., Ali, A., et al. Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation 135 (2017), 2106–2211.
20. Zou, J., Tran, D., Baalbaki, M., et al. An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish. Elife, 4, 2015, e09406.
21. Shimizu, I., Minamino, T., Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97 (2016), 245–262.
22. Xu, L., Brink, M., mTOR, cardiomyocytes and inflammation in cardiac hypertrophy. Biochim Biophys Acta 1863 (2016), 1894–1903.
23. Schafer, S., de Marvao, A., Adami, E., et al. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet 49 (2017), 46–53.
24. Pugh, T.J., Kelly, M.A., Gowrisankar, S., et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 16 (2014), 601–608.
25. Arbustini, E., Disertori, M., Narula, J., Primary prevention of sudden arrhythmic death in dilated cardiomyopathy: current guidelines and risk stratification. J Am Coll Cardiol HF 5 (2017), 39–43.